Recent advances in the treatment of systemic sclerosis associated interstitial lung disease.

导出 LinkOut

翻译打印收藏纠错

作者： Antoniya,Kamenova ^[1] ; Argyris,Tzouvelekis ^[2] ; George A,Margaritopoulos ^[1]

作者单位： Interstitial Lung Disease Unit, London North West University Hospital HT, London, United Kingdom. ^[1] Respiratory Medicine Department, University of Patras, Patras, Greece. ^[2]

关键词 cyclophosphamide interstitial lung disease mycophenolate mofetil nintedanib pirfenidone rituximab systemic sclerosis tocilizumab

DOI 10.3389/fmed.2023.1155771

PMID 37035331

发布时间 2023-04-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in medicine

2023年10卷

1155771页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Recent advances in the treatment of systemic sclerosis associated interstitial lung disease.

Frontiers in medicine

相似文献

Frontiers in medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Recent advances in the treatment of systemic sclerosis associated interstitial lung disease.

Frontiers in medicine

相似文献

Frontiers in medicine

相关期刊

检索历史清除